tradingkey.logo
tradingkey.logo

Twist Bioscience Corp

TWST
View Detailed Chart
44.530USD
-2.220-4.75%
Close 03/27, 16:00ETQuotes delayed by 15 min
1.18BMarket Cap
LossP/E TTM

Twist Bioscience Corp

44.530
-2.220-4.75%
Intraday
1m
30m
1h
D
W
M
D

Today

-4.75%

5 Days

+5.85%

1 Month

-5.09%

6 Months

+65.48%

Year to Date

+40.38%

1 Year

+7.09%

View Detailed Chart

Key Insights

Twist Bioscience Corp's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 30 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 50.60.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Twist Bioscience Corp's Score

Industry at a Glance

Industry Ranking
30 / 157
Overall Ranking
103 / 4542
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Twist Bioscience Corp Highlights

StrengthsRisks
Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. It has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The Company's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. It has minority ownership in Atlas Data Storage, Inc.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 53.63% year-on-year.
Undervalued
The company’s latest PE is -35.23, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 73.72M shares, decreasing 4.29% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 5.76M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.78.

Analyst Rating

Based on 11 analysts
Buy
Current Rating
50.600
Target Price
+6.55%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Twist Bioscience Corp News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Twist Bioscience Corp Info

Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. It has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The Company's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. It has minority ownership in Atlas Data Storage, Inc.
Ticker SymbolTWST
CompanyTwist Bioscience Corp
CEOLeproust (Emily M)
Websitehttps://www.twistbioscience.com/
KeyAI